Background and Purpose: To characterize clinically acute external (EcC) and extreme capsular (ExC) strokes in 9 patients with first-ever acute stroke. Methods: Nine patients with a lesion limited to the EcC-ExC region proven by diffusion-weighted imaging included in our registry, corresponding to 0.3% of 3,600 patients with ischemic stroke, were studied. Results: We found three main groups of clinical manifestations: (1) motor deficits in all patients (4 with faciobrachial, 2 with faciobrachiocrural, and 1 with brachiocrural, crural and facial paresis each); (2) hypesthesia in 3 patients with partial distribution concerning light touching without involvement of other sensory modalities; (3) transient speech disturbance at stroke onset in 1 patient and dysarthria in 2 patients. Small artery disease in 4 patients and artery-to-artery embolism in 3 patients probably from atherosclerotic carotid artery were the main stroke mechanism. Conclusions: Strokes restricted to the EcC-ExC region may present with complete or partial motor syndromes and dysarthria as prominent clinical presentations, but also fou rire prodromique and transient speech arrest as prodromal signs. The main etiology of stroke were microangiopathy and artery-to-artery embolism, even though no obvious cause was found in 1 patient. The prognosis was good in almost all patients.

Keywords:
Transient speech arrest, External and extreme capsular stroke, Diffusion-weighted imaging
1.
Cobb SR, Mehringer CM, Itabashi HH, Pribram H: CT of subinsular infarction and ischemia. Am J Neuroradiol 1987;8:221–227.
2.
Pullicino P, Miller LL, Munschauer FE, Ostrow PT: Linear subinsular MR hyperintensities. Ann Neurol 1992;32:267–268.
3.
Weiller C, Ringelstein EB, Reiche W, Thron A, Buell U: The large striatocapsular infact. A clinical and pathophysiological entity. Arch Neurol 1990;47:1085–1091.
4.
Boiten J, Lodder J: Large striatocapsular infarcts: clinical presentation and pathogenesis in comparison with lacunar and cortical infarcts. Acta Neurol Scand 1992;86:298–303.
5.
Bladin PF, Berkovics SF: Striatocapsular infarcts: large infarcts in the lenticulostriate artery territory. Neurology 1984;34:1423–1430.
6.
Tatu L, Moulin T, Bogousslavsky J, Duvernoy HM: Arterial vascular territories of human brain: hemispheres. Neurology 1998;50:1699–1708.
7.
Ture U, Yaşargil MG, Al-Mefty O, Yaşargil DC: Arteries of the insula. J Neurosurg 2000;92:676–687.
8.
Marinkovic SV, Milisavljevic MM, Kovacevic MS, Stevic ZD: Perforating branches of the middle cerebral artery. Stroke 1985;16:1022–1029.
9.
Warach S, Gaa J, Siewert B, Wielopolski P, Edelman RR: Acute human stroke studied by whole brain echo planar diffusion-weighted magnetic resonance imaging. Ann Neurol 1995;37:231–241.
10.
Kang DW, Latour LL, Chalela JA, Dambrosia JA, Warach S: Early and late recurrence of ischemic lesion on MRI. Evidence for a prolonged stroke-prone state? Neurology 2004;63:2261–2265.
11.
Kumral E, Ozkaya B, Sagduyu A, Sirin H, Vardarli E, Pehlivan M: The Ege Stroke Registry: a hospital-based study in the Aegean Region, İzmir, Turkey. Cerebrovasc Dis 1998;8:278–288.
12.
McLaughlin CT, Kane AG, Auber AE: MR imaging of heat stroke: external capsule and thalamic T1 shortening and cerebellar injury. Am J Neuroradiol 2003;24:1372–1375.
13.
Markus HS, Martin RJ, Simpson MA, Dong YB, Ali N, Crosby AH, Powel JF: Diagnostic strategies in CADASIL. Neurology 2002;59:1134–1138.
14.
Pullicino PM, Ostrow PT, Stone AD, Chakravorty SS: Striato-thalamic ischemic rarefaction: the basal penetrating artery counterpart of hemispheric white matter ischemic rarefaction. Stroke 1998;29:306.
15.
Bogousslavsky J, Regli F, Maeder P: Intracranial large-artery disease and lacunar infarction. Cerebrovasc Dis 1991;1:154–159.
16.
Baird AE, Lövblad KO, Schlaug G, Edelman RR, Warach S: Multiple acute stroke syndrome: marker of embolic disease? Neurology 2000;54:674–679.
17.
Alberts MJ, Faulstich ME, Gray L: Stroke with negative brain magnetic resonance imaging. Stroke 1992;23:663–667.
18.
Ceccaldi M, Milandre L: A transient fit of laughter as the inaugural symptom of capsular-thalamic infarction. Neurology 1994;44:1762.
19.
Carel C, Albucher JF, Manelfe C, Guiraud-Chaumeil B, Chollet F: Fou rire prodromique heralding a left internal carotid artery occlusion. Stroke 1997;28:2081–2083.
20.
Wilson SAK: Some problems in neurology. II. Pathologic laughing and crying. J Neurol Psychiatry 1924;16:299–333.
21.
Caselli RJ: Ventrolateral and dorsomedial somatosensory association cortex infarction produce distinct somesthetic syndromes. Neurology 1993;43:762–771.
22.
Kreisler A, Godefroy O, Delmaire C, et al: The anatomy of aphasia revisited. Neurology 2000;54:1117–1123.
23.
Damasio H, Damasio AR: The anatomical basis of conduction aphasia. Brain 1980;103:337–350.
24.
Herman LH, Ostrowski AZ, Gurdjian ES: Perforating branches of the middle cerebral artery. Arch Neurol 1963;1:32–34.
25.
Wong E, Pullicino PM, Benedict R: Deep cerebral infarcts extending to the subinsular region. Stroke 2001;32:2272–2277.
26.
Mounier-Vehier F, Leys D, Godelfroy O, Rondepierre P, Marchau M, Jr, Pruvo JP: Borderzone infarct subtypes: preliminary study of the presumed mechanism. Eur Neurol 1994;34:11–15.
© 2006 S. Karger AG, Basel
2006
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.